menu
    • menu

    Company profile for Numab Therapeutics

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    With Virupaksha, you get a quality product with on-time delivery.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-24

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    ChemExpress delivers end-to-end CRO & CDMO solutions for small molecules, biologics & new modalities with ICH-grade quality.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Numab Therapeutics is an oncology-focused biopharmaceutical company based in Zurich-area, Switzerland. At Numab, we are writing the next chapter in cancer immunotherapy by creating multispecific antibodies that enable the pursuit of novel therapeutic strategies. With our proprietary MATCH™ technology platform we are fueling a new wave of multi-specific drug candidates engineered with versatility and developability in mind...
    Numab Therapeutics is an oncology-focused biopharmaceutical company based in Zurich-area, Switzerland. At Numab, we are writing the next chapter in cancer immunotherapy by creating multispecific antibodies that enable the pursuit of novel therapeutic strategies. With our proprietary MATCH™ technology platform we are fueling a new wave of multi-specific drug candidates engineered with versatility and developability in mind. Our lead product was designed to balance potent anti-tumor immunity with a desirable safety profile by targeting 4-1BB, PD-L1 and Human Serum Albumin simultaneously.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Numab TherapeuticsSwitzerland Flag
    Country
    Country
    Switzerland
    Address
    Address
    Numab Therapeutics AG Einsiedlerstrasse 34 CH-8820 Wädenswil Switzerland
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://numab.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Numab Achieves Milestone in Collaboration with Boehringer
    Numab Achieves Milestone in Collaboration with Boehringer

    25 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/25/3156195/0/en/Numab-Therapeutics-Achieves-Milestone-in-Collaboration-with-Boehringer-Ingelheim.html

    GLOBENEWSWIRE
    25 Sep 2025
    Share Share
    Numab Therapeutics Appoints Angehrn Pavik as New CEO
    Numab Therapeutics Appoints Angehrn Pavik as New CEO

    09 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/09/3146807/0/en/Numab-Therapeutics-Announces-Leadership-Transition-and-Appoints-Angehrn-Pavik-as-Chief-Executive-Officer.html

    GLOBENEWSWIRE
    09 Sep 2025
    Share Share
    Numab Therapeutics Announces Series C Extension to CHF 180 Million
    Numab Therapeutics Announces Series C Extension to CHF 180 Million

    09 Jan 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/01/09/3007134/0/en/Numab-Therapeutics-Announces-Series-C-Extension-to-CHF-180-Million-Completing-Oversubscribed-CHF-50-Million-Financing.html

    GLOBENEWSWIRE
    09 Jan 2025
    Share Share
    Numab, Kaken Partner on ND081 for Inflammatory Bowel Disease
    Numab, Kaken Partner on ND081 for Inflammatory Bowel Disease

    15 Nov 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/11/15/2981815/0/en/Numab-Therapeutics-and-Kaken-Pharmaceutical-Enter-Collaboration-and-Option-Agreement-for-Multi-specific-Antibody-ND081-for-Treatment-of-Inflammatory-Bowel-Disease.html

    GLOBENEWSWIRE
    15 Nov 2024
    Share Share
    Biotechs behind J&J-bought Yellow Jersey partner on IBD drug
    Biotechs behind J&J-bought Yellow Jersey partner on IBD drug

    15 Nov 2024

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/biotechs-behind-jj-bought-yellow-jersey-partner-another-immunology-asset

    FIERCE BIOTECH
    15 Nov 2024
    Share Share
    Numab Therapeutics Launches Phase 1 Trial of NM32 in Tumors
    Numab Therapeutics Launches Phase 1 Trial of NM32 in Tumors

    30 Oct 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/10/30/2971606/0/en/Numab-Therapeutics-Announces-Initiation-of-Phase-1-Clinical-Study-of-NM32-Program-in-Patients-with-Solid-Tumors.html

    GLOBENEWSWIRE
    30 Oct 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search